OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ORSO58

Orsero SpA

Food Retail & DistributionVerified

Orsero's capital structure is characterized by a debt-to-equity ratio of 0.94, indicating a moderate reliance on debt financing. The company holds 88.04 million EUR in cash and equivalents, but its long-term debt of 228.74 million EUR suggests a net cash position that is negative after subtracting total debt. Free cash flow for the period was 5.41 million EUR, while operating cash flow was negative at -8.28 million EUR, signaling potential liquidity constraints. Profitability metrics show a return on equity of 1.89% and a return on assets of 0.68%, both of which are below the typical thresholds for strong performance in the retail sector. Gross profit of 31.51 million EUR and operating income of 8.68 million EUR indicate a narrow margin structure, which is common in the Food Retail & Distribution industry but leaves little room for error in cost management. Geographically and segment-wise, Orsero's revenue is concentrated in its core retail operations, with no disclosed diversification into other business lines or international markets. The company's exposure is primarily to the domestic market, and there is no indication of significant geographic diversification in the financial data. Looking ahead, Orsero's growth trajectory appears modest. Analysts have assigned a mean price target of 26.07 EUR, with a median of 25.90 EUR, and a mean recommendation of 1.75, suggesting a generally positive outlook. However, the absence of a clear revenue growth rate or segment-specific growth projections limits the visibility into the company's future performance. Risk factors include liquidity concerns, as the company's operating cash flow is negative and its free cash flow is relatively small. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet short-term obligations without external financing. Recent events and filings do not show any material changes in the company's operations or financial strategy. The absence of significant capital expenditures or new product launches in the latest financial data suggests a conservative approach to growth and investment.

30-day price · ORSO-0.42 (-2.7%)
Low$14.52High$17.10Close$15.04As of17 May, 00:00 UTC
Profile
CompanyOrsero SpA
TickerORSO.MI
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Orsero SpA operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.

Classification. Orsero is classified under the industry "Food Retail & Distribution" within the business sector "Food & Drug Retailing" and economic sector "Consumer Non-Cyclicals," with a confidence level of 0.92.

Orsero's capital structure is characterized by a debt-to-equity ratio of 0.94, indicating a moderate reliance on debt financing. The company holds 88.04 million EUR in cash and equivalents, but its long-term debt of 228.74 million EUR suggests a net cash position that is negative after subtracting total debt. Free cash flow for the period was 5.41 million EUR, while operating cash flow was negative at -8.28 million EUR, signaling potential liquidity constraints. Profitability metrics show a return on equity of 1.89% and a return on assets of 0.68%, both of which are below the typical thresholds for strong performance in the retail sector. Gross profit of 31.51 million EUR and operating income of 8.68 million EUR indicate a narrow margin structure, which is common in the Food Retail & Distribution industry but leaves little room for error in cost management. Geographically and segment-wise, Orsero's revenue is concentrated in its core retail operations, with no disclosed diversification into other business lines or international markets. The company's exposure is primarily to the domestic market, and there is no indication of significant geographic diversification in the financial data. Looking ahead, Orsero's growth trajectory appears modest. Analysts have assigned a mean price target of 26.07 EUR, with a median of 25.90 EUR, and a mean recommendation of 1.75, suggesting a generally positive outlook. However, the absence of a clear revenue growth rate or segment-specific growth projections limits the visibility into the company's future performance. Risk factors include liquidity concerns, as the company's operating cash flow is negative and its free cash flow is relatively small. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet short-term obligations without external financing. Recent events and filings do not show any material changes in the company's operations or financial strategy. The absence of significant capital expenditures or new product launches in the latest financial data suggests a conservative approach to growth and investment.
Key takeaways
  • Orsero has a moderate debt load and a negative net cash position, which could constrain its operational flexibility.
  • The company's profitability is weak, with low return on equity and return on assets, indicating limited efficiency in generating returns from its capital.
  • Revenue is concentrated in a single business line, with no evidence of geographic or product diversification.
  • Analysts are cautiously optimistic about Orsero's stock, but the lack of clear growth drivers and thin profit margins pose challenges for long-term value creation.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$337.9M
Gross profit$31.5M
Operating income$8.7M
Net income$4.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$8.3M
CapEx-$3.6M
Free cash flow$5.4M
Total assets$677.2M
Total liabilities$433.7M
Total equity$243.5M
Cash & equivalents$88.0M
Long-term debt$228.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.07B$23.1M$18.3M$15.7M
FY-3$1.20B$39.9M$32.3M$38.1M
FY-2$1.54B$64.9M$47.3M$60.1M
FY-1$1.57B$44.0M$26.8M$22.5M
FY0$1.70B$45.2M$29.2M$34.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$488.6M$175.2M$55.0M
FY-3$522.0M$201.1M$68.8M
FY-2$670.5M$236.8M$90.1M
FY-1$686.3M$254.7M$85.4M
FY0$698.5M$272.9M$77.7M
PeriodOCFCapExFCFSBC
FY-4$55.1M-$31.2M$15.7M
FY-3$54.9M-$29.4M$38.1M
FY-2$75.2M-$13.2M$60.1M
FY-1$64.5M-$26.3M$22.5M
FY0$56.2M-$21.0M$34.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$337.9M$8.7M$4.6M$5.4M
FQ-6
FQ-5$411.0M$16.6M$10.9M$5.4M
FQ-4
FQ-3$379.6M$12.1M$7.0M$8.7M
FQ-2
FQ-1$430.8M$15.9M$11.5M$14.4M
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$677.2M$243.5M$88.0M
FQ-6
FQ-5$708.8M$249.2M$86.6M
FQ-4
FQ-3$684.5M$258.5M$85.3M
FQ-2
FQ-1$724.2M$271.1M$83.9M
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$8.3M-$3.6M$5.4M
FQ-6
FQ-5$44.3M-$18.4M$5.4M
FQ-4
FQ-3$1.5M-$3.1M$8.7M
FQ-2
FQ-1$42.3M-$17.1M$14.4M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$243.5M
Net cash-$140.7M
Current ratio1.3
Debt/Equity0.9
ROA0.7%
ROE1.9%
Cash conversion-1.8%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricORSOActivity
Op margin2.6%3.1% medp25 1.2% · p75 6.8%below median
Net margin1.4%2.0% medp25 0.7% · p75 4.1%below median
Gross margin9.3%26.1% medp25 17.2% · p75 32.0%bottom quartile
CapEx / revenue-1.1%-2.5% medp25 -4.6% · p75 -1.4%top quartile
Debt / equity94.0%56.0% medp25 16.8% · p75 121.1%above median
Observations
IR observations
Mean price target26.07 EUR
Median price target25.90 EUR
High price target28.50 EUR
Low price target24.00 EUR
Mean recommendation1.75 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.51 EUR
Last actual EPS1.76 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 03:08 UTC#e248c6c3
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 21:23 UTCJob: a5aa0f1b